In summary, ANA to LEDGF/p75 over-expressing HEp-2 cells generated by CRISPR/Cas9 and anti-mDNA autoAbs by CLIFT could aid in the identification of BPH patients with an autoimmune involvement in combination with other prostate-specific autoAbs. The gene discussed is PSIP1; the disease is benign prostatic hyperplasia.